Trial intelligence / Profile preview

Lidocaine for Chronic Postoperative Pain After VATS

NCT02006966Completed

Sponsor
Yonsei University
Start
Jan 2014
Primary completion
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in chronic post-surgical pain (CPSP), sponsored by Yonsei University. Primary endpoint: Pain at 2 months. Started Jan 2014; status: completed.

02

Drugs

Lidocaine Hydrochloride Injection, without epinephrine
03

Conditions

chronic post-surgical pain (CPSP)

Beyond the preview

Go deeper on NCT02006966.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02006966.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call